Variant Bio

📍 Seattle, United States🗓 Founded 2018👥 47 employees💰 Last funded 2020
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Variant Bio?
Variant Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Variant Bio last raise funding?
The most recent investment in Variant Bio recorded on gritt.io was in 2020.
When was Variant Bio founded?
Variant Bio was founded in 2018.
What industry is Variant Bio in?
Variant Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Variant Bio based?
Variant Bio is headquartered in Seattle, United States.